Immix Biopharma | Investor Presentation Deck | 46 slides · page 45 of 46
The slide uses a bar chart to contrast the combined sales of two groups of oncology drugs ($33.4bn vs $0.9bn).
Pitch deck · market_sizing · size_opportunity · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 image 1/1 source-note 1/1 title 1/1
Components 4
bar-vertical logo-grid source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.